GlaxoSmithKline Pharmaceuticals Quarterly Results

Latest Quarter Net Profit
₹336 Cr
QSept 2026
Quarterly Results

GlaxoSmithKline Pharmaceuticals quarterly results. In Sept 2026, GlaxoSmithKline Pharmaceuticals (GLAXO) reported revenue ₹1,256 Cr and net profit ₹336 Cr — revenue +23.6% YoY. View GLAXO price range for the annual high/low range and current price position.

GLAXO Quarterly Results — Revenue, Profit & EPS Highlights

GlaxoSmithKline Pharmaceuticals latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore GLAXO share price charts to track price trends across different timeframes.

  • Revenue of ₹1,256 Cr in Sept 2026 (+21.8% vs Mar 2026, +23.6% vs Sept 2025)
  • Net Profit of ₹336 Cr in Sept 2026 (+20.9% vs Mar 2026, +30.2% vs Sept 2025)
  • EBITDA of ₹475 Cr in Sept 2026 (+22.7% vs Mar 2026)
  • Operating Margin of 34.0% in Sept 2026 (-1.0pp vs Mar 2026)
  • Earnings Per Share of ₹19.83 in Sept 2026 (+20.9% vs Mar 2026)

GlaxoSmithKline Pharmaceuticals Quarterly Results — Revenue, EBITDA, Net Profit & EPS

GLAXO quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 1,256 1,031 982 1,016 1,015 21.8% 23.6%
Net Profit (₹ Cr) 336 278 237 258 263 - -
EBITDA (₹ Cr) 475 387 339 372 374 - -
EPS (₹) 19.83 16.40 14.00 15.07 15.52 - -
Operating Margin (%) 34.0% 35.0% 31.0% 34.0% 34.0% - -

GLAXO Share Price Trend — 1-Year Movement Across Quarterly Results

GlaxoSmithKline Pharmaceuticals 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. For annual financials, live price and key ratios, visit GlaxoSmithKline Pharmaceutical share price chart.

Profitability Ratios

Profit Margin 26.8%
EBITDA Margin 37.8%
Operating Margin 34.0%
ROE (Annual) 59.3%

Balance Sheet Highlights

Total Assets ₹4,324 Cr
Total Equity ₹2,267 Cr
Current Assets ₹ Cr
Current Liabilities ₹277 Cr

Cash Flow Analysis

Operating Cash Flow ₹903 Cr
Investing Cash Flow ₹397 Cr
Financing Cash Flow ₹-737 Cr
Net Cash Flow ₹563 Cr

Current Market Data

Current Price ₹2713.40
Exchange NSE
Last Updated Nov 19, 2026

GLAXO vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

GlaxoSmithKline Pharmaceuticals latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores